Skip to main content

Mepivacaine Injection

Last Updated: January 23, 2023
Status: Current

Products Affected - Description
    • Polocaine injection, Fresenius Kabi, 1%, 50 mL multiple dose vial, NDC 63323-0283-57
    • Polocaine injection, Fresenius Kabi, 2%, 50 mL multiple dose vial, NDC 63323-0296-57
    • Polocaine-MPF injection, Fresenius Kabi, 1%, 30 mL preservative-free vial, NDC 63323-0260-37
    • Polocaine-MPF injection, Fresenius Kabi, 1.5%, 30 mL preservative-free vial, NDC 63323-0293-37
    • Polocaine-MPF injection, Fresenius Kabi, 2%, 20 mL preservative-free vial, NDC 63323-0294-27
Reason for the Shortage
    • Fresenius Kabi had Polocaine on shortage due to manufacturing delays.
    • Pfizer stopped marketing Carbocaine in June 2022. The 2% Carbocaine 50 mL vials were discontinued in April 2021.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Fresenius Kabi has 1% Polocaine 50 mL vials on back order and the company estimates a release date of late-February 2023. The 1% Polocaine-MPF 30 mL vials are on back order and the company estimates a release date of late-February 2023. The 1.5% Polocaine-MPF 30 mL vials are on back order and the company estimates a release date of early-February 2023. The 2% Polocaine-MPF 20 mL vials are on back order and the company estimates a release date of late-January 2023. The 2% Polocaine 50 mL vials are on back order and the company estimates a release date of late-February to early-March 2023.

Updated

Updated January 23, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 9, 2017 by Elyse MacDonald, PharmD, MS, BCPS. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.